A detailed history of Simplex Trading, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 42,915 shares of SGMO stock, worth $15,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,915
Previous 30,981 38.52%
Holding current value
$15,449
Previous $16,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$0.42 - $1.38 $5,012 - $16,468
11,934 Added 38.52%
42,915 $28,000
Q4 2023

Feb 02, 2024

SELL
$0.3 - $0.63 $2,551 - $5,357
-8,504 Reduced 21.54%
30,981 $16,000
Q3 2023

Nov 01, 2023

SELL
$0.58 - $1.47 $6,928 - $17,559
-11,945 Reduced 23.23%
39,485 $23,000
Q2 2023

Aug 04, 2023

BUY
$1.11 - $1.74 $26,782 - $41,982
24,128 Added 88.37%
51,430 $66,000
Q1 2023

Apr 27, 2023

BUY
$1.66 - $3.67 $27,773 - $61,402
16,731 Added 158.27%
27,302 $48,000
Q4 2022

Feb 02, 2023

SELL
$2.77 - $5.07 $47,674 - $87,259
-17,211 Reduced 61.95%
10,571 $33,000
Q3 2022

Nov 04, 2022

BUY
$4.27 - $6.39 $67,414 - $100,885
15,788 Added 131.63%
27,782 $136,000
Q2 2022

Aug 03, 2022

SELL
$3.28 - $6.21 $100,190 - $189,690
-30,546 Reduced 71.81%
11,994 $49,000
Q1 2022

May 02, 2022

SELL
$5.23 - $7.82 $52,362 - $78,293
-10,012 Reduced 19.05%
42,540 $247,000
Q4 2021

Feb 23, 2022

BUY
$7.29 - $10.97 $213,290 - $320,960
29,258 Added 125.6%
52,552 $394,000
Q3 2021

Oct 28, 2021

BUY
$9.01 - $12.01 $2,703 - $3,603
300 Added 1.3%
23,294 $279,000
Q2 2021

Aug 12, 2021

BUY
$10.17 - $12.64 $83,882 - $104,254
8,248 Added 55.93%
22,994 $275,000
Q1 2021

Apr 26, 2021

SELL
$10.88 - $17.05 $501,198 - $785,425
-46,066 Reduced 75.75%
14,746 $0
Q4 2020

Feb 02, 2021

BUY
$9.23 - $18.18 $292,037 - $575,215
31,640 Added 108.46%
60,812 $948,000
Q3 2020

Oct 14, 2020

SELL
$9.38 - $12.48 $328,937 - $437,648
-35,068 Reduced 54.59%
29,172 $275,000
Q2 2020

Jul 13, 2020

BUY
$6.21 - $11.83 $251,865 - $479,801
40,558 Added 171.26%
64,240 $575,000
Q1 2020

Apr 29, 2020

SELL
$5.05 - $8.85 $156,777 - $274,748
-31,045 Reduced 56.73%
23,682 $150,000
Q4 2019

Feb 05, 2020

BUY
$8.03 - $11.7 $27,607 - $40,224
3,438 Added 6.7%
54,727 $458,000
Q3 2019

Oct 15, 2019

BUY
$9.05 - $12.22 $5,701 - $7,698
630 Added 1.24%
51,289 $464,000
Q2 2019

Jul 26, 2019

BUY
$8.75 - $13.03 $360,578 - $536,953
41,209 Added 436.07%
50,659 $545,000
Q1 2019

Apr 18, 2019

SELL
$7.72 - $12.81 $237,235 - $393,651
-30,730 Reduced 76.48%
9,450 $0
Q4 2018

Jan 16, 2019

BUY
$9.51 - $16.6 $220,822 - $385,452
23,220 Added 136.91%
40,180 $461,000
Q3 2018

Oct 23, 2018

SELL
$13.05 - $19.05 $440,868 - $643,566
-33,783 Reduced 66.58%
16,960 $287,000
Q2 2018

Jul 30, 2018

BUY
$13.9 - $19.8 $4,767 - $6,791
343 Added 0.68%
50,743 $720,000
Q1 2018

Apr 26, 2018

BUY
$16.7 - $26.35 $841,680 - $1.33 Million
50,400 New
50,400 $957,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $56.4M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.